534 related articles for article (PubMed ID: 15882358)
21. Immunotherapy as treatment for Alzheimer's disease.
Hawkes CA; McLaurin J
Expert Rev Neurother; 2007 Nov; 7(11):1535-48. PubMed ID: 17997702
[TBL] [Abstract][Full Text] [Related]
22. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
23. Alzheimer's disease: Moving towards a vaccine.
Holtzman DM
Nature; 2008 Jul; 454(7203):418-20. PubMed ID: 18650906
[No Abstract] [Full Text] [Related]
24. Beta-amyloid immunisation in Alzheimer's disease.
Sorbi S
Neurol Sci; 2005 May; 26 Suppl 1():S5. PubMed ID: 15883696
[No Abstract] [Full Text] [Related]
25. Clearing tau pathology with Abeta immunotherapy--reversible and irreversible stages revealed.
Hutton M; McGowan E
Neuron; 2004 Aug; 43(3):293-4. PubMed ID: 15294135
[TBL] [Abstract][Full Text] [Related]
26. Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease.
Dodel R; Hampel H; Depboylu C; Lin S; Gao F; Schock S; Jäckel S; Wei X; Buerger K; Höft C; Hemmer B; Möller HJ; Farlow M; Oertel WH; Sommer N; Du Y
Ann Neurol; 2002 Aug; 52(2):253-6. PubMed ID: 12210803
[TBL] [Abstract][Full Text] [Related]
27. Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives.
Wang YJ; Zhou HD; Zhou XF
Drug Discov Today; 2006 Oct; 11(19-20):931-8. PubMed ID: 16997144
[TBL] [Abstract][Full Text] [Related]
28. Modulation of microglial activation state following passive immunization in amyloid depositing transgenic mice.
Morgan D
Neurochem Int; 2006 Jul; 49(2):190-4. PubMed ID: 16740342
[TBL] [Abstract][Full Text] [Related]
29. Anti-amyloid-beta immunotherapy in Alzheimer's disease: ACC-001 clinical trials are ongoing.
Ryan JM; Grundman M
J Alzheimers Dis; 2009; 17(2):243. PubMed ID: 19502708
[No Abstract] [Full Text] [Related]
30. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
Rakover I; Arbel M; Solomon B
Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden.
Kellner A; Matschke J; Bernreuther C; Moch H; Ferrer I; Glatzel M
Ann Neurol; 2009 Jan; 65(1):24-31. PubMed ID: 19194878
[TBL] [Abstract][Full Text] [Related]
32. Innate immunity in Alzheimer's disease: a model for local inflammatory reactions.
McGeer EG; McGeer PL
Mol Interv; 2001 Apr; 1(1):22-9. PubMed ID: 14993335
[TBL] [Abstract][Full Text] [Related]
33. Modulation of Alzheimer's pathology by cerebro-ventricular grafting of hybridoma cells expressing antibodies against Abeta in vivo.
Gaugler MN; Tracy J; Kuhnle K; Crameri A; Nitsch RM; Mohajeri MH
FEBS Lett; 2005 Jan; 579(3):753-6. PubMed ID: 15670841
[TBL] [Abstract][Full Text] [Related]
34. Amyloid-beta immunotherapies in mice and men.
Brendza RP; Holtzman DM
Alzheimer Dis Assoc Disord; 2006; 20(2):118-23. PubMed ID: 16772748
[TBL] [Abstract][Full Text] [Related]
35. [Anti-amyloid immunotherapy in Alzheimer's disease].
Orgogozo JM
Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F95-7. PubMed ID: 18680825
[No Abstract] [Full Text] [Related]
36. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
[TBL] [Abstract][Full Text] [Related]
37. Active immunization against Alzheimer's beta-amyloid peptide using phage display technology.
Solomon B
Vaccine; 2007 Apr; 25(16):3053-6. PubMed ID: 17287054
[TBL] [Abstract][Full Text] [Related]
38. In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques.
Poduslo JF; Ramakrishnan M; Holasek SS; Ramirez-Alvarado M; Kandimalla KK; Gilles EJ; Curran GL; Wengenack TM
J Neurochem; 2007 Jul; 102(2):420-33. PubMed ID: 17596213
[TBL] [Abstract][Full Text] [Related]
39. Amyloid imaging in Alzheimer's disease.
Nordberg A
Neuropsychologia; 2008; 46(6):1636-41. PubMed ID: 18468648
[TBL] [Abstract][Full Text] [Related]
40. Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety.
Okura Y; Miyakoshi A; Kohyama K; Park IK; Staufenbiel M; Matsumoto Y
Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9619-24. PubMed ID: 16769900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
